Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Mycophenolate mofetil by F. Hoffmann-La Roche for Lupus Nephritis: Likelihood of Approval
Mycophenolate mofetil is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Lupus Nephritis. According to...